Overview
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
Status:
Completed
Completed
Trial end date:
2015-01-01
2015-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine the efficacy and safety of OPC-1085EL ophthalmic solution in comparison with carteolol long-acting ophthalmic solution in subjects who are insufficiently responsive to carteolol long-acting ophthalmic solution.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.Treatments:
Carteolol
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Subjects with diagnosis of bilateral primary open-angle glaucoma or ocular
hypertension
Exclusion Criteria:
- Subjects with ocular conditions as defined by the protocol